NIH-funded research R21 grant

How bacteria modify their outer membrane to evade the immune system

Official title: Novel roles for lipopolysaccharide modifications in immune evasion

Funded at Duke University · NIH-10889028 · Data updated 2026-11-12

This study looks at how some bacteria change their outer layer to avoid being attacked by our immune system, which could help scientists find new ways to create better antibiotics for treating infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startJuly 17, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$231,231
NIH project number5R21AI169122-02
Project IDNIH-10889028 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from bacterial infections, particularly those caused by Gram-negative bacteria.

Less likely to help

Patients with infections caused by Gram-positive bacteria or those not affected by antibiotic resistance may not benefit from this research.

What this research studies

This research investigates how certain modifications in the outer membrane of Gram-negative bacteria help them evade the human immune system. It focuses on a component called lipopolysaccharide (LPS), which is crucial for the bacteria's ability to resist antimicrobial treatments. By understanding the specific changes in LPS that allow bacteria to escape immune detection, the research aims to identify new targets for antibiotic development. Patients may benefit from insights that could lead to more effective treatments for bacterial infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antibiotics that are more effective against resistant bacterial infections.

How similar studies have gone: Previous research has shown that understanding bacterial evasion mechanisms can lead to significant advancements in antibiotic therapies, indicating a promising avenue for this investigation.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Coers, Joern — Duke University
  • Study coordinator: Coers, Joern

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.